Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma

Fig. 2

utLIFE-UC MRD analysis in patients with localized bladder cancer. A Line chart of the utLIFE-UC score for 2 groups: patients with pCR and patients with non-pCR (student’s t test; *p < 0.05, **p < 0.01). B, C Stacked bar plots showing the proportions of each group with positive or negative utLIFE-UC scores of the training set (B) and the validation set (C). D The landscape of the utLIFE-UC MRD model, cytology, and FISH. E Diagnostic sensitivity and NPV of the utLIFE-UC MRD model compared to cytology or FISH (Fisher’s exact test; *p < 0.05, **p < 0.01)

Back to article page

Molecular Cancer

ISSN: 1476-4598